Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation

American Journal of Transplantation, 05/17/2012

Statins are considered the agents of choice, though their use may be complicated by drug misadventures. Pravastatin, fluvastatin and pitavastatin are considered to be the safest statins to use in this population; however, given their low–potency, a high–potency statin, such as atorvastatin, may be necessary in patients with significant dyslipidemia.

Print Article Summary Cat 2 CME Report